Laboratory Corp. of America Holdings (LH)

186.44
NYSE : Health Services
Prev Close 186.44
Day Low/High 0.00 / 0.00
52 Wk Low/High 146.68 / 190.35
Avg Volume 700.90K
Exchange NYSE
Shares Outstanding 102.30M
Market Cap 19.15B
EPS 12.40
P/E Ratio 15.43
Div & Yield N.A. (N.A)

Latest News

LabCorp Launches Proprietary UltraQual® Multiplex PCR Assay For HCV, HIV-1, HIV-2 And HBV

LabCorp Launches Proprietary UltraQual® Multiplex PCR Assay For HCV, HIV-1, HIV-2 And HBV

LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.

Laboratory Corporation Of America Holdings Achieves #62 Analyst Rank, Surpassing Align Technology

Laboratory Corporation Of America Holdings Achieves #62 Analyst Rank, Surpassing Align Technology

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Laboratory Corporation of America Holdings has taken over the #62 spot from Align Technology Inc , according to ETF Channel. Below is a chart of Laboratory Corporation of America Holdings versus Align Technology Inc plotting their respective rank within the S&P 500 over time (LH plotted in blue; ALGN plotted in green): In forming the rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components were ranked according to those averages.

LabCorp Expands Drug Development Solutions With Acquisition Of Sciformix

LabCorp Expands Drug Development Solutions With Acquisition Of Sciformix

LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has acquired Sciformix Corporation, a scientific process outsourcing company focused on pharmacovigilance and regulatory solutions for biopharmaceutical and medical...

LabCorp Is Scheduled To Present At The 38th Annual William Blair Growth Stock Conference

LabCorp Is Scheduled To Present At The 38th Annual William Blair Growth Stock Conference

LabCorp® (NYSE: LH) today announced it will participate at the 38 th Annual William Blair Growth Stock Conference.

Http://www.unilabs.com

Http://www.unilabs.com

LabCorp® (NYSE: LH), a leading global life sciences company, and Unilabs, a leading European provider of clinical laboratory testing and medical diagnostic imaging services, announced a strategic collaboration to provide expanded global development and...

Http://www.aetna.com

Http://www.aetna.com

Aetna (NYSE: AET) and LabCorp® (NYSE: LH) today extended and expanded their existing agreement, making LabCorp a preferred national laboratory for substantially all of Aetna's members beginning January 1, 2019.

UnitedHealthcare Establishes Long-term Strategic Partnership With LabCorp

UnitedHealthcare Establishes Long-term Strategic Partnership With LabCorp

UnitedHealthcare and LabCorp (NYSE: LH) have renewed their long-term strategic partnership as the two organizations focus on ways to create more personalized care recommendations and a simpler consumer experience for the more than 48 million people...

LabCorp To Webcast Its Annual Meeting Of Shareholders

LabCorp To Webcast Its Annual Meeting Of Shareholders

LabCorp® (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 10, 2018 at 9:00 a.

LabCorp Announces Collaboration With The Recovery Platform To Assist Physicians Treating Patients With Opioid Dependency

LabCorp Announces Collaboration With The Recovery Platform To Assist Physicians Treating Patients With Opioid Dependency

LabCorp® (NYSE: LH), a leading global life sciences company, and The Recovery Platform are announcing a new collaboration to expand access to medication-assisted opioid treatment on a national basis.

LabCorp Enters Into Definitive Agreement To Sell Covance Food Solutions To Eurofins For $670 Million

LabCorp Enters Into Definitive Agreement To Sell Covance Food Solutions To Eurofins For $670 Million

LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has entered into a definitive agreement under which Eurofins Scientific (EUFI.

LabCorp Announces Strong 2018 First Quarter Results And Updates 2018 Guidance

LabCorp Announces Strong 2018 First Quarter Results And Updates 2018 Guidance

LabCorp ® (or the Company) (NYSE: LH) today announced results for the first quarter ended March 31, 2018, and updated 2018 guidance.

LabCorp And Mount Sinai Health System Enhance Laboratory Operations To Improve Patient Care

LabCorp And Mount Sinai Health System Enhance Laboratory Operations To Improve Patient Care

LabCorp® (NYSE: LH) and the Mount Sinai Health System today announced a significant milestone in achieving their common goal of improving laboratory services and patient care.

LabCorp At Walgreens Expands Into Florida

LabCorp At Walgreens Expands Into Florida

Walgreens and LabCorp® (NYSE: LH) today announced the expansion of their LabCorp at Walgreens collaboration into Florida.

Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

Conversion Right Triggered For LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021

LabCorp® (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.

Http://www.arh.org

Http://www.arh.org

LabCorp® (NYSE: LH) and Appalachian Regional Healthcare have entered into a multi-year, comprehensive laboratory partnership.

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest

LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest

LabCorp® (NYSE: LH) announced today that for the period of March 12, 2018 to September 11, 2018, its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) will accrue (subject to the terms of the Zero...

Covance Forms Immunology & Immunotoxicology Unit Focused On Biologic Drug Development

Covance Forms Immunology & Immunotoxicology Unit Focused On Biologic Drug Development

LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the...

LabCorp Is Scheduled To Present At The 2018 Barclays Global Healthcare Conference

LabCorp Is Scheduled To Present At The 2018 Barclays Global Healthcare Conference

LabCorp® (NYSE: LH) today announced it will participate at the 2018 Barclays Global Healthcare Conference.

LabCorp Partners With Cheeriodicals Through Community Service Campaign To Florida Hospital Memorial Medical Center And Halifax Health Medical Center

LabCorp Partners With Cheeriodicals Through Community Service Campaign To Florida Hospital Memorial Medical Center And Halifax Health Medical Center

As part of a community service campaign, an enthusiastic group of LabCorp employees teamed up with Cheeriodicals to assemble and deliver 128 big green boxes to children patients at Florida Hospital Memorial Medical Center...

Covance Enters Into Strategic Technology Agreement With GSK

Covance Enters Into Strategic Technology Agreement With GSK

LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has entered into a strategic technology agreement with GlaxoSmithKline plc (GSK).

LabCorp Is Scheduled To Present At The 39th Annual Raymond James Institutional Investors Conference

LabCorp Is Scheduled To Present At The 39th Annual Raymond James Institutional Investors Conference

LabCorp® (NYSE: LH) today announced it will participate at the 39th Annual Raymond James Institutional Investors Conference.

LabCorp To Host Investor And Analyst Day On February 27, 2018

LabCorp To Host Investor And Analyst Day On February 27, 2018

LabCorp® (NYSE: LH), a leading global life sciences company, will host an Investor and Analyst Day for institutional investors and financial analysts in New York City on Tuesday, February 27, 2018.

Centene, LabCorp Among Healthcare Stock Gainers

Centene, LabCorp Among Healthcare Stock Gainers

Centene and Laboratory Corp. of America were among the healthcare stocks in the green on Tuesday, Feb. 6, amid a volatile trading day in the stock market.

LabCorp Announces Record 2017 Fourth Quarter And Full Year Results And Provides 2018 Guidance

LabCorp Announces Record 2017 Fourth Quarter And Full Year Results And Provides 2018 Guidance

LabCorp ® (or the Company) (NYSE: LH) today announced results for the fourth quarter and year ended December 31, 2017, and provided 2018 guidance.

LabCorp Named To FORTUNE Magazine's 2018 List Of 'World's Most Admired Companies'

LabCorp Named To FORTUNE Magazine's 2018 List Of 'World's Most Admired Companies'

Laboratory Corporation of America ® Holdings (LabCorp) (NYSE: LH), a leading global life sciences company, today announced that it has been named to FORTUNE magazine's 2018 List of World's Most Admired Companies.

Covance Introduces Dedicated Offering Designed For Biotech, Medical Device And Diagnostics Companies

Covance Introduces Dedicated Offering Designed For Biotech, Medical Device And Diagnostics Companies

LabCorp® (NYSE: LH), a leading global life sciences company, announced today that its Covance Drug Development (Covance) business has introduced a dedicated offering for biotech, medical device and diagnostics...

LabCorp Is Scheduled To Present At The 36th Annual J.P. Morgan Healthcare Conference

LabCorp Is Scheduled To Present At The 36th Annual J.P. Morgan Healthcare Conference

LabCorp® (NYSE: LH) today announced it will participate at the 36th Annual J.

TheStreet Quant Rating: A (Buy)